An HIV Prevention Pill for Transgender Persons
Awards & AccoladesThe California HIV/AIDS Research Program (CHRP) of University of California has awarded grants totaling $9.4 million to three teams of investigators to provide and evaluate PrEP – the HIV prevention pill – among transgender persons at risk for HIV acquisition in California.